amobarbital has been researched along with Hospital-Acquired Condition in 1 studies
Amobarbital: A barbiturate with hypnotic and sedative properties (but not antianxiety). Adverse effects are mainly a consequence of dose-related CNS depression and the risk of dependence with continued use is high. (From Martindale, The Extra Pharmacopoeia, 30th ed, p565)
amobarbital : A member of the class of barbiturates that is pyrimidine-2,4,6(1H,3H,5H)-trione substituted by a 3-methylbutyl and an ethyl group at position 5. Amobarbital has been shown to exhibit sedative and hypnotic properties.
Excerpt | Relevance | Reference |
---|---|---|
"In this investigation, we compared iLTS scar-derived fibroblasts in patients with and without T2DM." | 1.62 | Characterization of Fibroblasts in Iatrogenic Laryngotracheal Stenosis and Type II Diabetes Mellitus. ( Davis, R; Ding, D; Hillel, AT; Lina, I; Motz, KM; Tsai, HW, 2021) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Lina, I | 1 |
Tsai, HW | 1 |
Ding, D | 1 |
Davis, R | 1 |
Motz, KM | 1 |
Hillel, AT | 1 |
1 other study available for amobarbital and Hospital-Acquired Condition
Article | Year |
---|---|
Characterization of Fibroblasts in Iatrogenic Laryngotracheal Stenosis and Type II Diabetes Mellitus.
Topics: Adult; Aged; Amobarbital; Biopsy; Case-Control Studies; Cell Proliferation; Cells, Cultured; Cicatri | 2021 |